Should You Sell IDEXX Laboratories (IDXX)?
TimesSquare Capital Management released its Q4 2024 investor letter, discussing the U.S. Focus Growth Strategy's -1.35% (gross) and -1.56% (net) returns compared to the Russell Midcap Growth Index. IDEXX Laboratories, Inc.